With the analysis among 44 patents, we discovered top 14 key players by total patent application. Debregeas Et Associes Pharma, Novartis AG, F. Hoffmann-La Roche Ltd. are dominant in this area. They take 61.36% of the total patent filing.
Basel-Stadt, Switzerland
Patent: 7
Colorado, United States
Patent: 2
Delaware, United States
Patent: 1
Hubei Sheng, China
Patent: 1
No data, please try another search term
With the analysis among related 29 patents applied in the last 5 years. We discover 12 most active companies in this area. The fast-growing Novartis AG, Debregeas Et Associes Pharma, SOBR Safe, Inc. take 48.28% of patent filing during this period.
Basel-Stadt, Switzerland
Patent: 7
Colorado, United States
Patent: 2
Guangdong Sheng, China
Patent: 1
Hubei Sheng, China
Patent: 1
Heilongjiang Sheng, China
Patent: 1
undefined undefined
Patent: 1
Guangdong Sheng, China
Patent: 1
With the analysis among related 29 patents in last 5 years, we discover 11 new entrants. Novartis AG, SOBR Safe, Inc., Shenzhen People's Hospital are the most active new entrants in this area.
Basel-Stadt, Switzerland
Patent: 7
Colorado, United States
Patent: 2
Guangdong Sheng, China
Patent: 1
Hubei Sheng, China
Patent: 1
Heilongjiang Sheng, China
Patent: 1
undefined undefined
Patent: 1
Guangdong Sheng, China
Patent: 1
Henan Sheng, China
Patent: 1
With the analysis among 12 patents, we discovered top 6 universities and scientific research institutions by total patent application. The Scripps Research Institute, Zhejiang University of Technology, Heilongjiang University of Chinese Medicine are dominant in this area. They take 50.00% of the total patent filing.
California, United States
Patent: 4
Zhejiang Sheng, China
Patent: 1
Heilongjiang Sheng, China
Patent: 1
Heilongjiang Sheng, China
Patent: 1
Henan Sheng, China
Patent: 1